Oncimmune: Precision medicine company falls into administration

Oncimmune, a precision medicine company spun out from the University of Nottingham, has fallen into administration. It follows attempts by the business to sell its German trading subsidiary and a failure to raise additional capital required to meet the company's short term funding needs. Oncimmune has concluded that there are no further options available to [...]